Tuesday, January 25, 2011

Stock Idea: Sanofi Aventis (SNY, $34.56)

(May 16, 2011 update: All future stock posts will appear on my new subscription-only website at www.GoodfellowLLC.com. Please visit!)

Sanofi Aventis (SNY) is a healthcare company which produces human pharmaceuticals and vaccines and animal healthcare products.

SNY had a firm trading range of $40-$49 before the stock fell with the crash of 2008. The stock price is now recovering. I expect it to trade in the $34-$40 range in the near-term, and it could break through $40 without too much difficulty if market conditions remain strong.

SNY pays a dividend of $1.099 per share, with an attractive yield of 3.18%. The PE is 8.55 (very low!) and the beta is 0.91. EPS are consistently in the $4.50 area going back to 2009 and forward to 2011. All-in-all, Sanofi Aventis appears to be a good value stock with immediate upside potential.


The Right Huff is Crista Huff's blog for politics and items of sociological or financial interest. Crista Huff also manages Goodfellow LLC, a subscription-only stock market website. We strive to identify financially healthy companies in which traders and investors can buy shares and earn dividends and capital gains. See disclaimer for the risks associated with investing in the stock market. See your tax advisor for the tax consequences of investing. See your estate planning attorney to clarify beneficiary and inheritance issues associated with your assets.

Investment Disclaimer

Release of Liability: Through use of this website viewing or using you agree to hold www.TheRightHuff.blogspot.com and me, Crista Huff, harmless and to completely release www.TheRightHuff.blogspot.com and Crista Huff from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur.

I am not paid to promote nor disparage any investment. My recommendations are based on hypothetical situations of what I would do, not advice on what you should do. The information provided herein is obtained from sources believed to be reliable but is not guaranteed as to accuracy or completeness. Investments are risky, and can go down in value. Past investment results are not indicative of future returns. I am not a licensed investment advisor nor a tax advisor. Consult with a licensed investment advisor and a tax advisor to determine the suitability of any investment. This is not a solicitation to buy or sell any security.

No comments: